|
T6SS-positive
|
T6SS-negative
|
p-value
|
---|
(n = 20)
|
(n = 99)
|
---|
Baseline characteristics
| | | |
Age (median years)
|
58 (46–77)
|
57 (31–74)
|
n.s.
|
Male gender
|
13 (65.0)
|
61 (61.6)
|
n.s.
|
Hospitalised patients
|
12 (60.0)
|
61 (61.6)
|
n.s.
|
Duration of hospital stay (median days)
|
3 (0–5)
|
1 (0–5)
|
n.s.
|
ICU stay (yes)
|
1 (5.0)
|
1 (1.0)
|
n.s.
|
Comorbidities
| | | |
Charlson Comorbidity Index
|
2 (1–5)
|
0 (0–1)
|
< 0.001
|
Solid organ transplant
|
4 (20.0)
|
3 (3.0)
|
0.015
|
Immunosuppressant therapy
|
6 (30.0)
|
9 (9.1)
|
0.019
|
Clinical characteristics
| | | |
Bacteraemia
|
0 (0.0)
|
6 (6.1)
|
n.s.
|
Fever history (yes)
|
6 (30.0)
|
56 (56.6)
|
0.048
|
Bloody diarrhoea (yes)
|
2 (10.0)
|
19 (19.2)
|
n.s.
|
Duration of diarrhoea (days)
|
6 (4–10)
|
6 (4–9)
|
n.s.
|
Leucocytes (× 109/l)
|
8.5 (6.1–12.1)
|
8.7 (5.9–11.1)
|
n.s.
|
Antibiotic therapy (yes)
|
13 (65.0)
|
60 (60.6)
|
n.s.
|
- Data are median (IQR) or n (%). P values ≤0.05 are shown. Only p-values of significant results were shown. n.s. non-significant